We are live on ! Find out more
HLF icon

Herbalife

218 hedge funds and large institutions have $871M invested in Herbalife in 2025 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 27

23% more call options, than puts

Call options by funds: $88.5M | Put options by funds: $71.9M

4% more funds holding

Funds holding: 210218 (+8)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

4% less capital invested

Capital invested by funds: $904M → $871M (-$32.9M)

9% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 76

2.72% less ownership

Funds ownership: 102.64%99.93% (-2.7%)

Holders
218
Holders Change
+8
Holders Change %
+3.81%
% of All Funds
2.86%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
38
Increased
69
Reduced
76
Closed
27
Calls
$88.5M
Puts
$71.9M
Net Calls
+$16.6M
Net Calls Change
+$12.3M
Name Holding Trade Value Shares
Change
Change in
Stake
DWM
51
Diversify Wealth Management
Utah
$2.79M +$661K +70,061 +25%
Group One Trading
52
Group One Trading
Illinois
$2.73M +$70.3K +7,451 +2%
State of Wisconsin Investment Board
53
State of Wisconsin Investment Board
Wisconsin
$2.46M +$729K +77,324 +36%
Parallax Volatility Advisers
54
Parallax Volatility Advisers
California
$2.27M +$1.06M +112,812 +72%
SEI Investments
55
SEI Investments
Pennsylvania
$2.23M -$67.2K -7,123 -3%
D.E. Shaw & Co
56
D.E. Shaw & Co
New York
$2.12M +$709K +75,227 +43%
PCM
57
Prentice Capital Management
Connecticut
$2.04M +$82.8K +8,776 +4%
N
58
Nuveen
North Carolina
$2M -$4.09M -434,001 -65%
WAM
59
Wolverine Asset Management
Illinois
$1.91M
Ameriprise
60
Ameriprise
Minnesota
$1.81M -$1.66M -175,670 -45%
AIM
61
AXA Investment Managers
France
$1.71M +$1.91M +202,274 New
IECM
62
Intrinsic Edge Capital Management
Illinois
$1.69M +$1.89M +200,000 New
Swiss National Bank
63
Swiss National Bank
Switzerland
$1.67M +$19.8K +2,100 +1%
UBS AM
64
UBS AM
Illinois
$1.61M -$965K -102,316 -35%
Fidelity Investments
65
Fidelity Investments
Massachusetts
$1.48M +$1.59M +168,537 +2,692%
JP Morgan Chase
66
JP Morgan Chase
New York
$1.43M -$25.4K -2,698 -2%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$1.3M -$47.3K -5,019 -3%
Marshall Wace
68
Marshall Wace
United Kingdom
$1.25M -$366K -38,830 -21%
Barclays
69
Barclays
United Kingdom
$1.21M -$497K -52,721 -27%
Los Angeles Capital Management
70
Los Angeles Capital Management
California
$1.05M -$273K -28,922 -19%
OSAM
71
O'Shaughnessy Asset Management
Connecticut
$1.05M +$77K +8,161 +7%
Verition Fund Management
72
Verition Fund Management
Connecticut
$1.02M -$114K -12,128 -9%
Franklin Resources
73
Franklin Resources
California
$1.01M +$203K +21,577 +22%
Russell Investments Group
74
Russell Investments Group
United Kingdom
$993K -$9.38K -995 -0.8%
Legal & General Group
75
Legal & General Group
United Kingdom
$977K -$30.3K -3,213 -3%

HLF Hedge Fund Activity: Q3 2025 in Review

218 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Herbalife (HLF) for Q3 2025, worth a combined $871M — down 3.6% from $904M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HLF positions and 27 closed out — a net gain of 11 holders — while 69 added to existing stakes and 76 trimmed.

The largest buyer was Quantedge Capital, adding an estimated $18.1M. The largest seller was Goldman Sachs, cutting an estimated $8.71M.

  • 218 institutional investors held Herbalife (HLF) as of Q3 2025, up from 210 in Q2 2025.
  • Funds reported $871M of Herbalife stock for Q3 2025, down 3.6% quarter-over-quarter.
  • 38 funds opened new Herbalife positions in Q3 2025 and 27 closed out, a net change of +11 holders.
  • The largest Herbalife buyer in Q3 2025 was Quantedge Capital, an estimated $18.1M added.
  • The largest Herbalife seller in Q3 2025 was Goldman Sachs, an estimated $8.71M sold.

Based on aggregated 13F filings for Q3 2025.